The patient with diabetes mellitus: Etiology, epidemiology, principles of medical management, oral disease burden, and principles of dental management

Quintessence International

Volumn 36, Issue 10, 2005, Pages 779-795

  Miley, D Douglas ^a   Terezhalmy, Geza T ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DENTAL CARE; DIABETES MELLITUS; HEART DISEASE; HUMAN; HYPOGLYCEMIA; MOUTH DISEASE; PATHOPHYSIOLOGY;

DENTAL CARE FOR CHRONICALLY ILL; DIABETES COMPLICATIONS; DIABETES MELLITUS; HEART DISEASES; HUMANS; HYPOGLYCEMIA; MOUTH DISEASES;

EID: 26844571442     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (98)

1. Cancer statistics - 2003. CA A Cancer Journal for Clinicians 2003;53:16-17.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27(Suppl 1):S5-S10.
3. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes. N Engl J Med 1994;331:1428-1436.
4. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A. Autoantibodies in newly diagnosed diabetic children with immunoprecipitate human pancreatic proteins. Nature 1982;298:167-169.
5. Atkinson MA, Maclaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP. Are insulin autoantibodies markers for insulin-dependent mellitus? Diabetes 1986;35:894-898.
6. Kaufman D, Erlander M, Clare-Salzer M, Atkinson M, Maclaren N, Tobin A. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent mellitus. J Clin Invest 1992;89:283-292.
7. Christie MR, Tun RY, Lo SSS, et al. Antibodies to GAD and tryptic fragments of islet 64K antigen as direct markers for development of IDDM: Studies with identical twins. Diabetes 1992;41:782-787.
8. Schott M, Schatz D, Atkinson M, et al. GAD65 autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes mellitus. J Autoimmunity 1994;7:865-872.
9. Schmidli RS, Colman PG, Harrison LC. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM? J Autoimmunity 1994;7:873-879.
10. Myers MA, Rabin DU, Rowley MJ. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 1995;44:1290-1295.
11. Lan MS, Wasserfall C, Maclaren NK, Notkins AL. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1996;93:6367-6370.
12. Lu J, Li Q, Xie H, et al. Identification of a second transmembrane protein tyrosine phosphatase, IA-2b, as an autoantigen in insulin-dependent diabetes mellitus: Precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci USA 1996;93:2307-2311.
13. Cantor AB, Krischer JP, Cithbertson DD, et al. Age and family relationship accentuate the risk of IDDM in relatives of patients with insulin-dependent diabetes. J Clin Endocrinol Metab 1995;80:3739-3743.
14. Huang W, Connor E, DelaRosa T, et al. Although DR3-DQB1* may be associated with multiple component diseases of the autoimmunepolyglandular syndromes, the human leukocyte antigen DR4-DQB110302 haplotype is implicated only in beta-cell autoimmunity. J Clin Endocrinol Metab 1996;81:1-5.
15. Banerji M, Lebovitz H. Insulin sensitive and insulin resistant variants in IDDM. Diabetes 1989;38:784-792.
16. Reaven GM, Bernstein R, Davis B, Olefsky JM. Nonketotioc diabetes mellitus: Insulin deficiency or insulin resistance? Am J Med 1976;60:80-88.
17. Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol 1982;243:E15-E30.
18. DeFonzo R, Deibert D, Hendler R, Felig P. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. J Clin Invest 1979;63:939-946.
19. Turner RC, Holman RR, Matthews D, Hockaday TDR, Peto J. Insulin deficiency and insulin resistance interaction in diabetes: Estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 1979;28:1086-1096.
20. Kolterman OG, Gray RS, Griffin J, et al. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest 1981;68:957-969.
21. Boradus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 1985;248:E286-E291.
22. Kissebah AH, Vydelingum N, Murray R, et al. Relationship of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54: 254-260.
23. Zimmet PZ. Kelly West Lecture 1991. Challenges in diabetes epidemiology - From West to the rest. Diabetes Care 1992;15:232-252.
24. Harris MI, Couric CC, Reiber G, Boyko E, Stern M, Bennett P (eds). Diabetes in America, 2nd ed. NIH publication 95-1468. Washington, DC, I.S. Government Printing Office, 1995 (NIH publ. No. 95-1468).
25. Fujimoto WY, Leonetti DL, Kinyoun JL, Shuman WP, Stolov WC, Wahl PW. Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance or normal glucose tolerance. Diabetes 1987;36:730-739.
26. Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabetes. Diabetes Care 2004;27(suppl 1):S84-S87.
27. American Diabetes Association. Nephropathy in diabetes. Diabetes Care 2004;27(suppl 1):S79-S83.
28. American Diabetes Association. Hypertension management in adults with diabetes. Diabetes Care 2004;27(suppl 1):S65-S67.
29. American Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care 2004;27(suppl 1):S68-S71.
30. Klein MI. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258-268.
31. Boulton AJM, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care 2004;27:1458-1486.
32. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003;26:1553-1579.
33. Mayrhofer M, Rabin DU, Messenger L, Standl E, Ziegler AG. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes. Exp Clin Endocrinol Diabetes 1996;104:228-234.
34. Bringley PJ, Christie MR, Bonifacio E, et al. Combined analyses of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994;43:1304-1310.
35. Verge CF, Gianani R, Kawasaki E, Chase H, Eisenbarth GS. Prediction of type 1 diabetes in the first degree relatives using a combination of insulin, GAD and ICA512bc/IA-2 autoantibodies. Diabetes 1996;45:926-933.
36. Hagopian WA, Sanjeevi CB, Kockum I, et al. Glutamate decarboxylase-, insulin, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995;95:1505-1511.
37. Harris MI. Undiagnosed NIDDM: Clinical and public heath issues. Diabetes Care 1993;16:642-652.
38. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26:S5-S20.
39. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the U.S. population aged 20-74 years. Diabetes 1987;36:523-534.
40. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004;27:S11-S14.
41. Knowler WC. Screening for NIDDM: Opportunities for detection, treatment and prevention. Diabetes 1994;17:445-450.
42. Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: An analysis using glycated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA 1996;276:1246-1252.
43. McCance DR, Hanson RL, Charles MA, et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994;308:1323-1328. Erratum in BMJ 1994 Oct;309: 841.
44. Engelgau MM, Thompson TJ, Herman WH, et al. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes: Diagnostic criteria and performance revisited. Diabetes 1997;20:785-791.
45. Jackson CA, Yudkin JS, Forrest RD. A comparison of the relationships of the glucose tolerance test and the glycated hemoglobin assay with diabetic vascular disease in the community: The Islington Diabetes Survey. Diabetes Res Clin Pract 1992;17:111-123.
46. Beks PJ, Mackay AJC, de Neeling JND, de Vries H, Bouter LM, Heine RJ. Peripheral arterial disease in relation to glycaemic level in elderly Caucasian population: The Hoorn Study. Diabetologia 1995;38:86-96.
47. American Diabetes Association. Nutritional principles and recommendations in diabetes. Diabetes Care 2004;27:S36-S46.
48. American Diabetes Association. Physical activity/exercise and diabetes. Diabetes Care 2004;27(suppl 1):S58-S62.
49. American Diabetes Association. Insulin administration. Diabetes Care 2004;27(suppl 1):S106-S109.
50. Abramowicz M (ed). Drugs for diabetes. Treatment guidelines from the Medical Letter. 2002;1(1): 1-6.
51. Ficara AJ, Levin MP, Grower MF, Kramer GD. A comparison of the glucose and protein content of gingival crevicular fluid from diabetics and nondiabetics. J Periodontal Res 1975; 10:171-175.
52. Seppala B, Sorsa T, Ainamo J. Morphometric analysis of cellular and vascular changes in gingival connective tissue in long-term insulin-dependent diabetes. J Periodontol 1997; 68:1237-1245.
53. Rose LF, Genko RJ, Mealey BL, Cohen WD. Diabetes Mellitus. B. C. Decker Inc., Hamilton, Canada 2000: Diabetes Mellitus p 122-150.
54. Offenbacher S. 1996 World Workshop in Clinical Periodontics. Periodontal diseases: Pathogenesis. Ann Periodontol 1996;1:821-878.
55. American Academy of Periodontology. Diabetes and periodontal disease (position paper). J Periodontol 1999;70:935-949.
56. Cianciola RJ, Park BH, Bruck E, Mosovich L, Genco RJ. Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes). J Am Dent Assoc 1982;104:653-660.
57. Schlossman M, Knowler WC, Pettitt DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc 1990;121:532-536.
58. Iacopino AM. Periodontitis and diabetes interrelationships: Role of inflammation. Ann Periodontol 2001;6:125-137.
59. Taylor GW. Periodontal treatment and its effect on glycemic control: A review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:311-316.
60. Cherry-Peppers G, Sorkin J, Andres R, Baum BJ, Ship JA. Salivary gland function and glucose metabolic status. J Gerontol 1992;47:M130-M134.
61. Sreebny LM, Yu A, Green A, Valdini A. Xerostomia in diabetes mellitus. Diabetes Care 1992; 15:900-904.
62. Ben-Aryeh H, Serouya R, Kanter Y, Szargel R, Laufer D. Oral health and salivary composition in diabetic patients. J Diabetes Complications 1993;7:57-62.
63. Moore PA, Guggenheimer J, Etzel KR, Weyant RJ, Orchard T.Type 1 diabetes mellitus, xerostomia, and salivary flow rates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:281-291.
64. Murrah VA, Crosson JT, Sauk JJ. Parotid gland basement membrane variation in diabetes mellitus. J Oral Pathol 1985; 14:236-246.
65. Russotto SB. Asymptomatic parotid gland enlargement in diabetes mellitus. Oral Surg Oral Med Oral Pathol 1981;52:594-598.
66. Meurman JH, Collin HL, Niskanen L, et al. Saliva in non-insulin-dependent diabetic patients and control subjects: The role of the autonomic nervous system. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1988;86:69-76.
67. Jones RB, McCallum RM, Kay EJ, Kirkin V, MacDonald P. Oral health and oral health behaviour in a population of diabetic outpatient clinic attenders. Community Dent Oral Epidemiol 1992;20:204-207.
68. Lin BP, Taylor, GW, Allen DJ, Ship JA. Dental caries in older adults with diabetes mellitus. Spec Care Dentist 1999; 19:8-14.
69. Collin HL, Uusitupa M, Niskanen L, Koivisto AM, Markkanen H, Meurman JH. Caries in patients with non-insulin-dependent diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85:680-685.
70. Rossie K, Guggenheimer J. Oral Candidiaosis: Clinical manifestations, diagnosis, and treatment. Prac Periodontics Aesthet Dent 1997;9:635-641.
71. Cannon RD, Holmes AR, Mason AB, Monk B. Oral Candida: Clearance, colonization, or candidiaosis? J Dent Res 1995; 74: 1152-1159.]
72. Fisher BM, Lamey PJ, Samaranayake LP, MacFarlane TW, Frier BM. Carriage of Candida species in the oral cavity in diabetic patients: Relationship to glycaemic control. J Oral Pathol 1987;16:282-284.
73. Guggenheimer J, Moore PA, Rossie K, et al. Insulin-dependent diabetes mellitus and oral soft tissue pathologies: II. Prevalence and characteristics of Candida and candidal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:570-576.
74. Epstein JB, Polsky B. Oropharyngeal candidiaosis: A review of its clinical spectrum and current therapies. Clin Ther 1998;20:40-57.
75. Aminoff MJ, Miller AL. The prevalence of diabetes mellitus in patients with Bell's palsy. Acta Neurol Scand 1972;48:381-384.
76. Abraham-Inpijn L, Devriese PP, Hart AA. Predisposing factors in Bell's palsy: A clinical study with reference to diabetes mellitus, hypertension, clotting mechanisms and lipid disturbance. Clin Otolaryngol Allied Sci 1982;7:99-105.
77. Abraham-Iinpijn L, Oosting J, Hart AA. Bell's palsy: fFactors affecting prognosis in 200 patients with reference to hypertension and diabetes mellitus. Clin Otolaryngol Allied Sci 1987;12:349-355.
78. Stevens JC, Smith BE. Cranial reflexes. In: Daube RJ (ed). Clinical Neurophysiology. Philadelphia:FA Davis, 1966:321-335.
79. Rhodus NL, Carlson CR, Miller CS. Burning mouth (syndrome) disorder. Quintessence Int 2003;34:587-593.
80. Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome. Am Fam Physician 2002: 15;65:615-620.
81. Stolbova K, Hahn A, Benes B, Andel M, Treslova L. Gustometry of diabetes mellitus and obese patients. Int Tinnitus J 1999; 5:135-140.
82. Bagán-Sebastián JV, Milián-Masanet MA, Peñarrocha-Diago M, Jiménez Y. A clinical study of 205 patients with oral lichen planus. J Oral Maxillofac Surg 1992;50:116-118.31.
83. Lundström IM. Incidence of diabetes mellitus in patients with oral lichen planus. Int J Oral Surg 1983;12:147-52. 32.
84. Petrou-Amerikanou C, Markopoulos AK, Belazi M, Karamitsos D, Papanayotou P. Prevalence of oral lichen planus in diabetes mellitus according to the type of diabetes. Oral Dis 1998;4:37-40.]
85. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: A report of the American College of Cardiology/American Heart Associoation Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Amn Coll Cardiol 2002;39:542-553.
86. Bruce RA. Exercise testing for evaluation of ventricular function. N Engl J Med 1977;296:671-675.
87. Kenney WL (ed). ACSM's Guidelines for exercise testing and prescription, 5th ed. Baltimore: Williams and Wilkin: 1995:93-94.
88. Niwa H, Satoh, Y, Matsuura H. Cardiovascular responses to epinephrine-containing local anesthetics for dental use: A comparison of hemodynamic responses to infiltration anesthesia and ergometer-stress testing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:171-81.
89. Siegenthaler W, Veragut M, Werning C. Blood pressure in westernized populpations. In: swales JD (ed). Textbook of Hypertension, ed 1. London: Blackwell, 1994:728.
90. Steinhauer T, Bsoul SA, and Terezhalmy GT. Risk stratification and dental management of the patient with cardiovascular diseases. Part I: Etiology, epidemiology, and principles of medical management. Quintessence Int 2005;36: 119-137.
91. Steinhauer T, Bsoul SA, and Terezhalmy GT. Risk stratification and dental management of the patient with cardiovascular diseases. Part II: The oral disease burden and principles of dental management. Quintessence Int 2005;36:209-227.
92. Lockhart PB, Schmidtke MA. Antibiotic considerations in medically compromised patients. Dent Clin North Am 1994;38:381-402.
93. Hall EH, Sherman RG, Emmons III WW III, Naylor GD. Antibacterial prophylaxis. Dent Clin North Am 1994;38:707-718.
94. Kim RB, (ed). The Medical Letter Handbook of Adverse Drug Interactions. New Rochelle, NY: The Medical Letter, Inc, 2003:142.
95. Kim RB, (ed). The medical letter handbook of adverse drug interactions. New Rochelle, NY: The Medical Letter, Inc. New Rochelle, N.Y. 2003:143.
96. Keltjens H, Schaeken T, van der Hoeven H. Preventive aspects of root caries. Int Dent J 1993;43:143-148.
97. Ten Cate JM, Parsh PD. Procedures for establishing efficacy of antibacterial agents for chemotherapeutic caries prevention. J Dent Res 1994;73:695-703.
98. Brailsford SR, Fiske J, Gilbert S, Clark D, Beighton D. The combination of fluoride and chlorehexidinethymol varnishes prevents progression of root surface caries in institutionalized elderly patients. J Dent 2002;30:319-324.